Evidence map›Paper›PMID 33083239›Full record

ArticleMethodsX2020

An efficient method for the construction of artificial, concatemeric DNA, RNA and proteins with genetically programmed functions, using a novel, vector-enzymatic DNA fragment amplification-expression technology.

Piotr M Skowron, Natalia Krawczun, Joanna Żebrowska, Daria Krefft, Olga Żołnierkiewicz, Marta Bielawa, Joanna Jeżewska-Frąckowiak, Łukasz Janus, Małgorzata Witkowska, Małgorzata Palczewska and 1 more

Abstract read
In one paragraph

Article in MethodsX, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Piotr M SkowronDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Natalia KrawczunDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Joanna ŻebrowskaDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Daria KrefftDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Olga ŻołnierkiewiczDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Marta BielawaBioVentures Institute Ltd., Poznan 60-141, Poland.
Joanna Jeżewska-FrąckowiakDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Łukasz JanusDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Małgorzata WitkowskaDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Małgorzata PalczewskaDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.
Agnieszka Zylicz-StachulaDepartment of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk 80-308, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

De novo designed bioactive molecules, such as DNA, RNA and peptides, are utilized in increasingly diverse scientific, industrial and biomedical applications. Concatemerization of designed DNA, RNA and peptides may improve their stability, bioactivity and allow for gradual release of the bioactive molecule at the intended destination. In this context, we developed a new method enabling the formation of DNA concatemers for the production of artificial, repetitive genes, encoding concatemeric RNAs and proteins of any nucleotide and amino-acid sequence. The technology recruits the Type IIS SapI restriction endonuclease (REase) for assembling DNA fragments in an ordered head-to-tail-orientation. Alternatively, other commercially available SapI isoschizomers can be used: LguI and thermostable BspQI. Four series of DNA vectors dedicated to the expression of newly formed, concatemeric open reading frames (ORFs), were designed and constructed to meet the technology needs. • Vector-enzymatic DNA fragment amplification technology. • Construction of DNA concatemers many times longer than those available with the use of current de novo gene synthesis methods. • Biosynthesis of protein tandem repeats with programmable function never seen in nature.

Indexed as

Artificial proteinsConcatemersDNA fragment amplificationGene expressionPeptide-based biomaterialsProtein purificationTandem DNA multimers

Identifiers

PMID33083239
PMCPMC7551362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.